Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    "Lymphangiectasis"
Show Display Options
Rank Status Study
1 Recruiting Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders
Conditions: Lymphangiomatosis;   Lymphedema;   Lymphangiectasia;   Pulmonary Lymphangiectasia
Intervention:
2 Active, not recruiting Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Conditions: Kaposiform Hemangioendotheliomas;   Tufted Angioma;   Capillary Venous Lymphatic Malformation;   Venous Lymphatic Malformation;   Microcystic Lymphatic Malformation;   Mucocutaneous Lymphangiomatosis and Thrombocytopenia;   Capillary Lymphatic Arterial Venous Malformations;   PTEN Overgrowth Syndrome With Vascular Anomaly;   Lymphangiectasia Syndromes
Intervention: Drug: sirolimus
3 Recruiting National Lymphatic Disease and Lymphedema Registry
Condition: Lymphedema
Intervention:

Indicates status has not been verified in more than two years